Immupharma PLC Result of AGM (6736O)
May 29 2015 - 6:50AM
UK Regulatory
TIDMIMM
RNS Number : 6736O
Immupharma PLC
29 May 2015
FOR IMMEDIATE RELEASE 29 MAY 2015
ANNUAL GENERAL MEETING: 2015
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the
specialist drug discovery and development company, held its AGM
earlier today and is pleased to announce that all resolutions were
duly passed. A summary of proxy votes is shown in the table below.
Please also refer to the 'Notice of the 2015 Annual General
Meeting' in the Report & Accounts - 31 December 2014 (page
55).
RESOLUTION FOR + % AGAINST % WITHHELD
DISCRETION
------------- ------------ ------ ---------- ----- ---------
1 37,051,623 91.52 3,432,424 8.48 300
------------- ------------ ------ ---------- ----- ---------
2 40,327,447 99.61 156,900 0.39 0
------------- ------------ ------ ---------- ----- ---------
3 40,327,447 99.61 156,900 0.39 0
------------- ------------ ------ ---------- ----- ---------
4 40,443,946 99.90 40,000 0.10 0
------------- ------------ ------ ---------- ----- ---------
5 40,441,085 99.90 41,800 0.10 1,462
------------- ------------ ------ ---------- ----- ---------
6 (Special
Resolution) 40,323,858 99.61 159,762 0.39 727
------------- ------------ ------ ---------- ----- ---------
For further information please see the Group's web site,
www.immupharma.org, or contact:
END
For further information please contact:
+ 44 (0) 20 7152
ImmuPharma plc 4080
Dimitri Dimitriou, Chief Executive
Officer
Dr Robert Zimmer, President
and Chief Scientific Officer
Lisa Baderoon, Head of Investor
Relations + 44 (0) 7721 413496
Panmure, Gordon & Co., NOMAD
& Broker +44 (0) 20 7886 2500
Hugh Morgan
Fred Walsh
Duncan Monteith
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGDMGZKMLLGKZM
Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2024 to May 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From May 2023 to May 2024
